logo
episode-header-image
Jan 2023
18m 6s

The Tiktok trending weight loss drug

LiSTNR
About this episode

Ozempic is a drug used to treat type 2 diabetes and obesity but social media influencers have now turned it into the most popular weight loss drug. Promotion of the drug has led to a shortage of supply with Australia's drugs regulator now investigating the matter. However, other issues have contributed to the lack of supply and influencers have promoted weight loss supplements for years. So why is TGA looking into the particular promotion of Ozempic?

 

In this episode we speak to public health advisor on nutrition, Professor Tim Gill, to find out what’s different about the promotion of this specific drug.

 

Headlines:

  • Djokovic wins 10th Australian Open title
  • Four dead in NZ floods
  • Missing radioactive capsule in WA
  • Good news for the Aussie tv and film industry. 

Follow The Briefing:

Instagram: @thebriefingpodcast 
Facebook: TheBriefingNewsAU
Twitter: @TheBriefingAU

See omnystudio.com/listener for privacy information.

Up next
Yesterday
BONUS: Inside the fight to free Kathleen Folbigg
Kathleen Folbigg was once branded Australia’s worst female serial killer, convicted of murdering her four children and locked away for 20 years. But she was innocent. In 2023, a breakthrough in genetics and the work of 90 leading scientists finally cleared Kathleen’s name and set ... Show More
32m 24s
Aug 22
How Natalie Kyriacou is saving the planet with snake clits and fish STDs
Natalie Kyriacou is the environmentalist saving the planet one snake clit and fish STD at a time. Before she turned 30, she was awarded an Order of Australia Medal for her contributions to wildlife conservation and education. Creating World of the Wild, a app that’s been dubbed t ... Show More
40m 10s
Aug 22
The job with a doubled suicide rate + Shock Menendez parole ruling
The construction industry has one of the highest suicide rates in the Australia, with employees twice as likely to die compared to other male workers. An often-toxic workplace environment and poor mental health are major contributing factors with experts calling for urgent action ... Show More
17m 9s
Recommended Episodes
Jan 2025
Life after Ozempic
Americans were told “diet and exercise” was the key to better health, but lifestyle changes were never that life changing. Medication is.This episode was produced by Miles Bryan, edited by Jolie Myers, fact-checked by Laura Bullard, engineered by Patrick Boyd and Andrea Kristinsd ... Show More
25m 6s
Aug 2024
Why Weight Loss Medications Are Shaking Up the Food Industry
In this episode, we continue our conversation with Marion Nestle. We discuss why food companies are scrambling due to the rising popularity of the new weight loss medications. We explore how our food system is designed more for animal feed and fuel than for human consumption. Fin ... Show More
4m 18s
Dec 2024
A checkup on weight-loss drugs
What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ... Show More
20m 17s
Jul 2024
Ozempic 101: A doctor explains the data and science behind weight-loss drugs
News about weight-loss drugs is hard to miss. A new generation of drugs — Ozempic, Wegovy, Mounjaro, Zepbound — are on television, on billboards, and in many of our homes. There is little debate about the efficacy of the drugs for weight loss (they work, at least for most people) ... Show More
52m 23s
May 2023
The Weight Loss Trends Episode
In this episode, we delve into some of the latest weight loss trends and take a closer look at two drugs specifically, Wegovy and Ozempic. Our guest, Dr. Dana Kerges, a family medicine doctor board certified in obesity medicine, shares valuable insights on the latest weight loss ... Show More
23m 20s
Jan 2025
Dr. Ania Jastreboff
In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront ... Show More
58m 54s
Jul 2
Why We’re Fatter Than Ever - Mike Israetel
Mike Israetel is a bodybuilder, exercise scientist, fitness trainer, nutritionist and YouTuber. | SPONSOR. Venice AI: Enjoy private, uncensored AI with our sponsor https://venice.ai/triggernometry - use code TRIGGERNOMETRY to get 20% off a pro plan SPONSOR. Try Evening Being by V ... Show More
1h 25m
May 30
What happened to body positivity?
Jenny Stevens and Gina Tonic discuss the rise of #SkinnyTok and the popularity of weight-loss drugs. Help support our independent journalism at theguardian.com/infocus 
31m 5s
Aug 2024
Could Popular Weight Loss Drugs Help Prevent Cancer?
In this episode, Dr. Diane Reidy-Lagunes sits down with MSK’s Dr. Neil Iyengar, a nationally recognized expert on the relationship between obesity, metabolic health, and cancer. Together, they discuss the intriguing connection between a new class of weight loss drugs, called GLP- ... Show More
17m 51s
Sep 2024
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks
Karen Andersen, biotechnology strategist for Morningstar Research Services, discusses what GLP-1 drugs’ demand means for the biopharma industry’s five-year outlook. And whether the weight-loss drugs pose a threat to snack food stocks.Why GLP-1 Drugs Are in Demand Competition Betw ... Show More
14m 33s